This study is looking at how physical activity and quality of life are connected in people with fibrotic lung diseases (like IPF, or idiopathic pulmonary fibrosis) who have recently started anti-fibrotic medicine and pulmonary rehabilitation. Researchers will use a special watch called an Actigraph CP Insight Watch to track your physical activity, movement, and sleep. They want to see if changes in your activity levels can help predict how your disease might progress. The study will also explore if your activity levels relate to your quality of life, how far you can walk in six minutes, your fatigue, and your breathing difficulties. This study aims to gather important information for both patient care and future research.

Study design

This is a prospective study involving 70 participants with fibrotic lung diseases. It will follow participants for 52 weeks.

What's involved

You would wear a special watch, complete a pulmonary rehabilitation program, and have routine clinical assessments including medical history, breathing tests, and a six-minute walk test. You would also fill out several questionnaires.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 52 weeks after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.